Occudo Quantitative Strategies LP Arvinas, Inc. Transaction History

Occudo Quantitative Strategies LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$36.38 - $52.31 $392,321 - $564,111	-10,784 Reduced 68.06%	5,060 $208,000
Q4 2023 Feb 14, 2024	BUY	$14.19 - $42.33 $224,826 - $670,676	15,844 New	15,844 $652,000
Q2 2023 Aug 14, 2023	SELL	$21.73 - $31.43 $224,253 - $324,357	-10,320 Reduced 44.99%	12,620 $313,000
Q1 2023 May 15, 2023	BUY	$26.15 - $37.26 $444 - $633	17 Added 0.07%	22,940 $626,000
Q4 2022 Feb 14, 2023	BUY	$32.47 - $57.24 $526,143 - $927,516	16,204 Added 241.17%	22,923 $784,000
Q3 2022 Nov 14, 2022	BUY	$41.87 - $57.99 $8,583 - $11,887	205 Added 3.15%	6,719 $299,000
Q2 2022 Aug 15, 2022	BUY	$36.01 - $74.24 $20,129 - $41,500	559 Added 9.39%	6,514 $274,000
Q1 2022 May 16, 2022	SELL	$60.27 - $81.57 $101,494 - $137,363	-1,684 Reduced 22.04%	5,955 $401,000
Q4 2021 Feb 14, 2022	SELL	$65.85 - $96.21 $253,193 - $369,927	-3,845 Reduced 33.48%	7,639 $627,000
Q3 2021 Nov 15, 2021	BUY	$73.2 - $107.87 $169,604 - $249,934	2,317 Added 25.28%	11,484 $944,000
Q2 2021 Aug 16, 2021	SELL	$60.45 - $84.26 $381,620 - $531,933	-6,313 Reduced 40.78%	9,167 $706,000
Q1 2021 May 14, 2021	BUY	$58.19 - $91.37 $137,735 - $216,272	2,367 Added 18.05%	15,480 $1.02 Million
Q4 2020 Feb 16, 2021	BUY	$20.19 - $84.93 $264,751 - $1.11 Million	13,113 New	13,113 $1.11 Million

224

70.9M

1.52M

346K

Ticker ARVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,205,300
Market Cap $986M
Description
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.